首页> 外国专利> Fatty acid-drug conjugates for drug delivery for crossing the blood-brain barrier

Fatty acid-drug conjugates for drug delivery for crossing the blood-brain barrier

机译:脂肪酸-药物结合物,用于跨血脑屏障的药物递送

摘要

The invention involves the formation of a prodrug from a fatty acid carrier and a neuroactive drug. The prodrug is stable in the environment of both the stomach and the bloodstream and may be delivered by ingestion. The prodrug passes readily through the blood brain barrier. Once in the central nervous system, the prodrug is hydrolyzed into the fatty acid carrier and the drug to release the drug. In a preferred embodiment, the carrier is 4,7,10,13,16,19 docosahexa-enoic acid and the drug is dopamine. Both are normal components of the central nervous system. The covalent bond between the drug and the carrier preferably is an amide bond, which bond may survive the conditions in the stomach. Thus, the prodrug may be ingested and will not be hydrolyzed completely into the carrier molecule and drug molecule in the stomach.
机译:本发明涉及由脂肪酸载体和神经活性药物形成前药。该前药在胃和血流的环境中都是稳定的,并且可以通过摄取来递送。前药容易通过血脑屏障。一旦进入中枢神经系统,前药就会水解成脂肪酸载体和药物,从而释放出药物。在一个优选的实施方案中,载体是4,7,10,13,16,19二十二碳六烯酸,药物是多巴胺。两者都是中枢神经系统的正常组成部分。药物和载体之间的共价键优选是酰胺键,该键可以在胃中存活。因此,前药可以被摄入并且不会完全水解成胃中的载体分子和药物分子。

著录项

  • 公开/公告号JP2959784B2

    专利类型

  • 公开/公告日1999-10-06

    原文格式PDF

  • 申请/专利权人 SHASHOA UIKUTAA II;

    申请/专利号JP19890503859

  • 发明设计人 SHASHOA UIKUTAA II;

    申请日1989-02-24

  • 分类号C07C233/09;A61K31/00;A61K31/165;C07C233/27;A61K233/49;

  • 国家 JP

  • 入库时间 2022-08-22 02:30:31

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号